A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopathic gastroparesis severity in adult subjects. The...
Different Doses of Naronapride Vs. Placebo in Gastroparesis
This is a double-blind, randomized, multicenter, placebo-controlled, comparative phase II dose-finding trial. The trial will be conducted with four treatment groups in the form of a parallel group com...
Top Cities for Gastroparesis Clinical Trials
Gastroparesis clinical trials are recruiting across 17 cities. Here are the cities with the most active studies:
About Gastroparesis
Gastroparesis is a condition that affects the normal movement of muscles in the stomach, causing delayed gastric emptying. It is commonly associated with diabetes. Treatment includes dietary modifications, medications to stimulate stomach motility, and in severe cases, gastric electrical stimulation.
Clinical trials are advancing new treatments for gastroparesis. Currently, 2 studies are recruiting a combined 720 participants across the United States. Research is being conducted by 2 organizations including CinDome Pharma, Inc., Dr. Falk Pharma GmbH.
2026 Gastroparesis Research Landscape
As of March 2026, the gastroparesis clinical trial landscape includes 2 actively recruiting studies across 17 cities in the United States. These studies are collectively seeking 720 participants, with an average enrollment target of 360 per study.
Research is being led by 2 different organizations, including CinDome Pharma, Inc., Dr. Falk Pharma GmbH.
Geographically, gastroparesis trials are most concentrated in Little Rock, Arkansas (2 trials); Chula Vista, California (2 trials); Miami, Florida (2 trials); Birmingham, Alabama (1 trial); Foley, Alabama (1 trial) and 7 other cities.
Featured Gastroparesis Studies
Highlighted recruiting studies for gastroparesis, selected by enrollment size and research scope.
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopathic gastroparesis severity in adult subjects. The main questions it aims to answer are: * To evaluate the efficacy of CIN-102 on symptoms of gastroparesis when given to patients with idiopathic gastroparesis compared to a placebo * To evaluate the ...
Different Doses of Naronapride Vs. Placebo in Gastroparesis
This is a double-blind, randomized, multicenter, placebo-controlled, comparative phase II dose-finding trial. The trial will be conducted with four treatment groups in the form of a parallel group comparison and will serve to compare oral treatment with daily doses of 10, 20, or 40 mg Naronapride vs. placebo for the treatment of patients with Gastroparesis.
Frequently Asked Questions About Gastroparesis Clinical Trials
Are there gastroparesis clinical trials near me?
Yes, there are 2 gastroparesis clinical trials currently recruiting across 17+ cities in the United States, including Little Rock, Arkansas; Chula Vista, California; Miami, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a gastroparesis clinical trial?
To join a gastroparesis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are gastroparesis clinical trials free?
Yes, participation in gastroparesis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of gastroparesis treatments are being studied?
Current gastroparesis clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in gastroparesis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov